These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 25487403

  • 1. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
    Eppler E, Janas E, Link K, Weidmann L, Bischofberger H, Wenger M, Tinguely M, Schraml P, Moch H, Fellbaum C.
    Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
    [Abstract] [Full Text] [Related]

  • 2. Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.
    Carbone A, Gloghini A, Castagna L, Santoro A, Carlo-Stella C.
    J Pathol; 2015 Sep; 237(1):4-13. PubMed ID: 25953622
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
    Koh YW, Yoon DH, Suh C, Cha HJ, Huh J.
    Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
    [Abstract] [Full Text] [Related]

  • 4. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A, Wacker HH, Rajewsky K, Küppers R, Hansmann ML.
    Cancer Res; 2003 Apr 01; 63(7):1644-51. PubMed ID: 12670918
    [Abstract] [Full Text] [Related]

  • 5. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD, Kamper P, Nielsen PS, Bendix K, Riber-Hansen R, Steiniche T, Hamilton-Dutoit S, Clausen M, d'Amore F.
    Eur J Haematol; 2016 Mar 01; 96(3):252-9. PubMed ID: 25963595
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA, Talks KL, Turley H, Debnam P, Tan DC, Mariatos G, Gorgoulis V, Kittas C, Gatter KC.
    J Pathol; 2002 Aug 01; 197(5):677-83. PubMed ID: 12210089
    [Abstract] [Full Text] [Related]

  • 7. Lymphomagenesis in Hodgkin lymphoma.
    Matsuki E, Younes A.
    Semin Cancer Biol; 2015 Oct 01; 34():14-21. PubMed ID: 25725205
    [Abstract] [Full Text] [Related]

  • 8. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A, Visser L, Poppema S.
    Am J Pathol; 1999 Jun 01; 154(6):1685-91. PubMed ID: 10362793
    [Abstract] [Full Text] [Related]

  • 9. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
    Xiao Q, Shen N, Hedvat CV, Moskowitz CH, Sussman LK, Filippa DA, Zelenetz AD, Houldsworth J, Chaganti RS, Teruya-Feldstein J.
    Appl Immunohistochem Mol Morphol; 2004 Sep 01; 12(3):211-5. PubMed ID: 15551733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS, Said JW.
    Am J Pathol; 1988 Nov 01; 133(2):211-7. PubMed ID: 3263805
    [Abstract] [Full Text] [Related]

  • 13. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A, Rüdiger T, Marx A, Müller-Hermelink HK, Ott G.
    Histopathology; 2005 Feb 01; 46(2):217-28. PubMed ID: 15693895
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said JW.
    Am J Pathol; 1997 Feb 01; 150(2):543-62. PubMed ID: 9033270
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments.
    Atayar C, van den Berg A, Blokzijl T, Boot M, Gascoyne RD, Visser L, Poppema S.
    J Clin Pathol; 2007 Oct 01; 60(10):1092-7. PubMed ID: 17158640
    [Abstract] [Full Text] [Related]

  • 20. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
    Yurchenko M, Sidorenko SP.
    Exp Oncol; 2010 Dec 01; 32(4):214-23. PubMed ID: 21270747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.